Loading stock data…
$6.23
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally.
Emergent BioSolutions Inc. in the Healthcare sector is trading at $6.23 with a market capitalization of $346M. Wall Street consensus targets $11.00 (2 analysts), implying a +76.6% move over the next 12 months. The stock is currently near its 52-week low of $4.36, remaining 23.7% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the distress zone. Risk note: RSI 29 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $226.80M↑ | $149.70M↑ | $143.80M↓ | $222.00M↑ | $130.30M |
| Gross Profit | $129.70M↑ | $77.70M↑ | $58.90M↓ | $136.10M↑ | $63.40M |
| Operating Income | $66.20M↑ | $10.50M↑ | -$15.70M↓ | $76.50M↑ | $1.60M |
| Net Income | -$180.20M↓ | $6.80M↑ | -$54.60M↓ | $51.20M↑ | -$12.00M |
Emergent BioSolutions Inc., a life sciences company, provides preparedness and response solutions for accidental, deliberate, and naturally occurring public health threats in the United States, Canada, and internationally. It operates through Commerc...